dc.creatorBenites Zapata, Vicente A.
dc.creatorIgnacio Cconchoy, Felipe L.
dc.creatorUlloque Badaracco, Juan R.
dc.creatorHernandez Bustamante, Enrique A.
dc.creatorAlarcón Braga, Esteban A.
dc.creatorAl-Kassab Córdova, Ali
dc.creatorHerrera Añazco, Percy
dc.date.accessioned2023-10-18T19:37:10Z
dc.date.accessioned2024-05-03T19:25:08Z
dc.date.available2023-10-18T19:37:10Z
dc.date.available2024-05-03T19:25:08Z
dc.date.created2023-10-18T19:37:10Z
dc.date.issued2023-02-22
dc.identifierBenites, V. A., Ignacio, F. L., Ulloque, J. R., Hernandez, E. A., Alarcón, E. A., Al-Kassab, A., & Herrera, P. (2023). Vitamin B12 levels in thyroid disorders: A systematic review and meta-analysis. Frontiers in Endocrinology, 14, 1-14. https://doi.org/10.3389/fendo.2023.1070592
dc.identifier.
dc.identifierhttps://hdl.handle.net/11537/34604
dc.identifierFrontiers in Endocrinology
dc.identifierhttps://doi.org/10.3389/fendo.2023.1070592
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9280248
dc.description.abstractBackground and aims: Numerous studies have found an association between vitamin deficiency and thyroid disorders (TD). The presence of anti-parietal cell antibodies is indicative of reduced ability to absorb vitamin B12. Thus, this study reviewed the existing studies with the objective of assessing differences in the serum levels of vitamin B12 among patients with and without TD, the frequency of vitamin B12 deficiency in patients with TD, and the presence of anti-parietal cell antibodies in patients with TD. Methods: A meta-analysis of random-effects model was conducted to calculate pooled frequencies, mean differences (MD), and their respective 95% confidence intervals (CI). We identified 64 studies that met our inclusion criteria (n = 28597). Results: We found that patients with hypothyroidism had lower vitamin B12 levels than healthy participants (MD: −60.67 pg/mL; 95% CI: −107.31 to −14.03 pg/mL; p = 0.01). No significant differences in vitamin B12 levels were observed between healthy participants and patients with hyperthyroidism (p = 0.78), autoimmune thyroid disease (AITD) (p = 0.22), or subclinical hypothyroidism (SH) (p = 0.79). The frequencies of vitamin B12 deficiency among patients with hypothyroidism, hyperthyroidism, SH, and AITD were 27%, 6%, 27%, and 18%, respectively. Conclusions: Patients with hypothyroidism had lower levels of vitamin B12 than healthy participants. No significant differences were observed between vitamin B12 levels and hyperthyroidism, AITD, or SH. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=324422, identifier (CRD42022324422).
dc.languageeng
dc.publisherFrontiers Media S.A.
dc.publisherPE
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/3.0/us/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-CompartirIgual 3.0 Estados Unidos de América
dc.sourceUniversidad Privada del Norte
dc.sourceRepositorio Institucional - UPN
dc.subjectThyroid
dc.subjectVitamin B12
dc.subjectAutoimmune thyroid disease
dc.subjectHypothyroidism
dc.subjectHyperthyroidism
dc.subjectSubclinical hypothyroidism
dc.titleVitamin B12 levels in thyroid disorders: A systematic review and meta-analysis
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución